Key details
Sponsor
Saadyya Ahmed Abdalhamed Aladawi
Enrollment target
~30 participants
Primary completion
March 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 35 Years
Last updated February 2025